Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6316541 | 7086585 | I | 6316541-6 | 20090810 | 20090814 | 20090820 | EXP | US-GENENTECH-288720 | GNEFDAAERSPRD | 47 | M | Y | 20090820 | MD | UNITED STATES |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
6316541 | 1012078056 | PS | RITUXIMAB | 2 | 375 MG/M2, UNK | NOT REPORTED | |||||
6316541 | 1012078057 | SS | RITUXIMAB | 2 | 375 MG/M2, UNK | NOT REPORTED | |||||
6316541 | 1012078058 | SS | IFOSFAMIDE | 1 | INTRAVENOUS | 5000 MG/M2, UNK | |||||
6316541 | 1012078059 | SS | ETOPOSIDE | 1 | 200 MG/M2, Q12H | ||||||
6316541 | 1012078060 | SS | CARBOPLATIN | 1 | 700 MG, UNK | ||||||
6316541 | 1012078061 | C | PEGFILGRASTIM | 2 | 6 MG, UNK |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
6316541 | 1012078056 | B-CELL LYMPHOMA |
6316541 | 1012078058 | B-CELL LYMPHOMA |
6316541 | 1012078059 | B-CELL LYMPHOMA |
6316541 | 1012078060 | B-CELL LYMPHOMA |
6316541 | 1012078061 | DRUG USE FOR UNKNOWN INDICATION |
Outcome of event
Event ID | OUTC COD |
---|---|
6316541 | HO |
Reactions reported
Event ID | PT |
---|---|
6316541 | FEBRILE NEUTROPENIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
6316541 | 1012078056 | 20090501 | |||
6316541 | 1012078057 | 20090801 | |||
6316541 | 1012078058 | 20090801 | |||
6316541 | 1012078059 | 20090801 | |||
6316541 | 1012078060 | 20090801 | |||
6316541 | 1012078061 | 20090803 | 20090803 | 1 | DAY |